Reunion Neuroscience Inc. Common Shares
REUN
REUN was delisted on the 31st of July, 2023.
21 hedge funds and large institutions have $1.94M invested in Reunion Neuroscience Inc. Common Shares in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 11 closing their positions.
117% more capital invested
Capital invested by funds: $894K → $1.94M (+$1.05M)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
19% less funds holding
Funds holding: 26 → 21 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
Top Sellers
REUN Hedge Fund Activity: Q2 2023 in Review
21 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q2 2023, worth a combined $1.94M — up 117% from $894K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of REUN and 6 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $584K. The largest seller was Avidity Partners Management, exiting entirely with an estimated $104K sold.
- 21 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q2 2023, down from 26 in Q1 2023.
- Funds reported $1.94M of Reunion Neuroscience Inc. Common Shares stock for Q2 2023, up 117% quarter-over-quarter.
- 6 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q2 2023 and 11 closed out, a net change of -5 holders.
- The largest Reunion Neuroscience Inc. Common Shares buyer in Q2 2023 was Beryl Capital Management, an estimated $584K added.
- The largest Reunion Neuroscience Inc. Common Shares seller in Q2 2023 was Avidity Partners Management, an estimated $104K sold.
Based on aggregated 13F filings for Q2 2023.